News

Major League Baseball Teams Stand by ZetrOZ’s SAM 2.0 Ability to Help Athletes Recover From Muscle Injury Without Surgery

SAM 2.0, an FDA-cleared 2020 bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries has received positive feedback from athletes at nearly every skill level for its ability to penetrate deep into the tissue. Most notably, athletic staff from a number of professional major league baseball teams have shared their positive experiences with Sustained Acoustic Medicine-SAM, and its ability to accelerate the natural healing process without the need for surgery. Read more >>

Community helps Bryan man get life-changing technology

An amazing piece of technology has opened up a whole new world for a Williams County man. eSight glasses use a camera, a computer, high definition video and OLED screens to help people see. Benjamin Murray got his first pair four years ago. He received the latest version this week, and it’s all because of the generosity of a lot of people. Read more >>

Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary Endpoint

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced topline results from its 28-week Phase 2b study of lenabasum in patients with cystic fibrosis (CF). The study enrolled patients in the U.S., Canada and Europe at high risk for recurrent pulmonary exacerbations (PEx). Subjects received lenabasum or placebo added to their background treatments for CF. Read more >>

Elite Athletes Use ZetrOZ Systems’ sam® Technology to Heal Quicker and Avoid Surgery

sam® ultrasound, ZetrOZ Systems’ sustained acoustic medicine device, is the preferred healing solution of countless professional and collegiate athletes. The wearable, long-duration ultrasound technology helps athletes avoid surgery while accelerating natural healing, proving to be extremely valuable in cases of acute and chronic pain, especially those that involve soft tissue damage. Read more >>

Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical

Oncocyte Corporation, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has agreed to enter a licensing and collaboration agreement with Chronix Biomedical. Oncocyte is licensing Chronix’s patented CNI Monitor technology for the TheraSure™-CNI MONITOR clinical assay. Read more >>

The 100 People You Don’t Know But Should 2020

Sue Nolin VP, Inside Sales, Wasabi Technologies — When it comes to growing sales and its channel team, Wasabi turns to Nolin. She is constantly working to up the cloud storage vendor’s game when it comes to supporting solution providers’ sales efforts every day. She knows the channel is key to her and Wasabi’s success. Read more >>